References
- Mihai S, Codrici E, Popescu ID, et al. Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome. J Immunol Res. 2018;2018:2180373.10.1155/2018/2180373614677530271792
- Dungey M, Hull KL, Smith AC, Burton JO, Bishop NC. Inflammatory factors and exercise in chronic kidney disease. Int J Endocrinol. 2013;2013:569831.10.1155/2013/569831366622823737775
- Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif. 2015;39:84-92.10.1159/00036894025662331
- Neuen BL, Leather N, Greenwood AM, Gunnarsson R, Cho Y, Mantha ML. Neutrophil-lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients. Ren Fail. 2016;38:70-76.10.3109/0886022X.2015.110499026540580
- Brito GMC, Fontenele AMM, Carneiro ECRL, et al. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Nondialysis Chronic Kidney Patients. Int J Inflam. 2021;2021:6678960.10.1155/2021/6678960824525434257898
- Bolton CH, Downs LG, Victory JG, et al. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant. 2001;16:1189-1197.10.1093/ndt/16.6.118911390719
- Yilmaz G, Sevinc C, Ustundag S, et al. The relationship between mean platelet volume and neutrophil/lymphocyte ratio with inflammation and proteinuria in chronic kidney disease. Saudi J Kidney Dis Transpl. 2017;28:90-94.10.4103/1319-2442.19815228098108
- Kamis F, Bakirdogen S, Burcu Cam A. The relationship between renal resistive index and simple hematologic indices in patients with chronic kidney disease. J Health Sci Med. 2021;4:45-48.
- Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102:653-657.10.1016/j.amjcard.2008.05.00618773982
- Uthamalingam S, Patvardhan EA, Subramanian S, et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol. 2011;107:433-438.10.1016/j.amjcard.2010.09.03921257011
- Gibson PH, Cuthbertson BH, Croal BL, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 2010;105:186-191.10.1016/j.amjcard.2009.09.00720102916
- Park JJ, Jang HJ, Oh IY, et al. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2013;111:636-642.10.1016/j.amjcard.2012.11.01223273716
- Kocyigit I, Eroglu E, Unal A, et al. Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease. J Nephrol. 2013;26:358-365.10.5301/jn.500015222573523
- Ahbap E, Sakaci T, Kara E, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in end-stage renal disease. Clin Nephrol. 2016;85:199-208.10.5414/CN10858426521887
- Sevencan NO, Ozkan AE. Associations between neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, albuminuria and uric acid and the estimated glomerular filtration rate in hypertensive patients with chronic kidney disease stages 1-3. Arch Med Sci. 2019;15:1232-1239.10.5114/aoms.2018.76262676430631572468
- Binnetoglu E, Sengul E, Halhalli S, Dindar S, Sen H. Is Neutrophil Lymphocite Ratio an Indicator for Proteinuria in Chronic Kidney Disease? J Clin Lab Anal. 2014;28:487-492.10.1002/jcla.21715680745224659410
- Lee C, Park KH, Joo YS, et al. Low High-Sensitivity C-Reactive Protein Level in Korean Patients With Chronic Kidney Disease and Its Predictive Significance for Cardiovascular Events, Mortality, and Adverse Kidney Outcomes: Results From KNOW-CKD. J Am Heart Assoc. 2020;9:e017980.10.1161/JAHA.120.017980776341533092438
- Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int. 2005;68:237-245.10.1111/j.1523-1755.2005.00398.x15954913
- Hung AM, Ikizler TA, Griffin MR, et al. CRP polymorphisms and chronic kidney disease in the third national health and nutrition examination survey. BMC Med Genet. 2011;12:65.10.1186/1471-2350-12-65311917921569369
- Fried L, Solomon C, Shlipak M, et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol. 2004;15:3184-191.10.1097/01.ASN.0000146422.45434.3515579522
- Ichihara K, Tanaka T, Takahashi S, et al. Serum procalcitonin level in chronic hemodialytic patients with no evidence of bacterial infection. Ren Replace Ther. 2016;2:9.10.1186/s41100-016-0025-3
- Bergstrom J, Lindholm B. Malnutrition, cardiac disease, and mortality. Perit Dial Int. 1999;19(S2):S309-14.10.1177/089686089901902S52
- Liu C, Li H. Correlation of the severity of chronic kidney disease with serum inflammation, osteoporosis and vitamin D deficiency. Exp Ther Med. 2019;17:368-372.
- Tbahriti HF, Meknassi D, Moussaoui R, et al.Inflammatory status in chronic renal failure: The role of homocysteinemia and pro-inflammatory cytokines. World J Nephrol. 2013;2:31-37.10.5527/wjn.v2.i2.31378222224175263
- Lavín-Gómez BA, Palomar-Fontanet R, Gago-Fraile M, et al. Inflammation markers, chronic kidney disease, and renal replacement therapy. Adv Perit Dial. 2011;27:33-37.
- Adejumo OA, Okaka EI, Okwuonu CG, Iyawe IO, Odujoko OO. Serum C-reactive protein levels in pre-dialysis chronic kidney disease patientsin southern Nigeria. Ghana Med J. 2016;50:31-38.10.4314/gmj.v50i1.5499448027605722
- Lalramenga PC, Gupta S, Naveen P. Study of C-Reactive Protein Significance in Chronic Kidney Disease. International Journal of Contemporary Medical Research. 2019;6:22-25.10.21276/ijcmr.2019.6.6.48
- Pravin NB, Jayashree SB, Shilpa BA, Suhas SB, Anand PT. Study of serum uric acid and C-reactive protein levels in patients with chronic renal disease. Int J Biol Med Res. 2013;4:2758-2761.
- Abraham G, Sundaram V,Sundaram V, Matthew M, Leslie N, Sathiah V. C-reactive protein, a valuable predictive marker in chronic kidney disease. Saudi J Kidney Dis Transpl. 2009;20:811-815.
- Sharain K, Hoppensteadt D, Bansal V, Singh A, Fareed J. Progressive Increase of Inflammatory Biomarkers in Chronic Kidney Disease and End-Stage Renal Disease. Clin Appl Thromb Hemost. 2013;19:303-308.10.1177/107602961245493522865783
- Thaha M, Imroati TA, Wardana A, Widodo W, Pranawa P, Irwanadi C. Comparison of High-sensitivity C-reactive Protein Level between Chronic Kidney Disease Stages. Biomolecular And Health Science Journal. 2018;1:1-9.10.20473/bhsj.v1i1.8226
- Gao J, Wang A, Li X, et al. The Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Chronic Kidney Diseases. Kidney Blood Press Res. 2020;45:84-94.10.1159/00050425131794962
- Imig JD, Ryan MJ. Immune and inflammatory role in renal disease. Compr Physiol. 2013;3:957-976.
- Umeres-Francia GE, Rojas-Fernández MV, Herrera-Añazco P, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as risk factors for mortality in Peruvian adults with chronic kidney disease. Ren Replace Ther. 2020;8:30.10.1186/s41100-022-00420-9
- Sawant AC, Adhikari P, Narra SR, Srivatsa SS, Mills PK, Srivatsa SS. Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction. Cardiol J. 2014;21:500-508.10.5603/CJ.a2013.014824142685
- Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102:653-657.10.1016/j.amjcard.2008.05.00618773982
- Wan H, Wang Y, Fang S, et al. Associations between the Neutrophil-to-Lymphocyte Ratio and Diabetic Complications in Adults with Diabetes: A Cross-Sectional Study. J Diabetes Res. 2020;2020:6219545.10.1155/2020/6219545720687532405503
- Gibson PH, Cuthbertson BH, Croal BL, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 2010;105:186-191.10.1016/j.amjcard.2009.09.00720102916
- Okyay GU, Inal S, Oneç K, et al. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Ren Fail. 2013;35:29-36.10.3109/0886022X.2012.73442923113674
- Kocyigit I, Eroglu E, Unal A, et al. Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease. J Nephrol. 2013;26:358-365.10.5301/jn.500015222573523
- Jaaban M, Zetoune AB, Hesenow S, Hessenow R. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as novel risk markers for diabetic nephropathy in patients with type 2 diabetes. Heliyon. 2021;7:e07564.10.1016/j.heliyon.2021.e07564832673034368476
- Winter L, Wong LA, Jerums G, et al. Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease. Front Endocrinol (Lausanne). 2018;9:225.10.3389/fendo.2018.00225599240029910771
- Sambel M, Kilic M, Demirbas M, et al. Relationship between erectile dysfunction and the neutrophil to lymphocyte and platelet to lymphocyte ratios. Int J Impot Res. 2018;30:27-35.10.1038/s41443-017-0007-129196693
- Tola EN. The association between in vitro fertilization outcome and the inflammatory markers of complete blood count among nonobese unexplained infertile couples. Taiwan J Obstet Gynecol. 2018;57:289-294.10.1016/j.tjog.2018.02.01929673675
- Fukuda H, Takagi T, Kondo T, Shimizu S, Tanabe K. Predictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy. Oncotarget. 2018;9:14296-14305.10.18632/oncotarget.24507586567029581844
- Uzun F, Erturk M, Cakmak HA, et al. Usefulness of the platelet-tolymphocyte ratio in predicting long-term cardiovascular mortality in patients with peripheral arterial occlusive disease. Postepy Kardiol Interwencyjnej. 2017;13:32-38.
- Yüksel M, Yıldız A, Oylumlu M, et al. The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol. 2015;15:640-647.10.5152/akd.2014.5565533686525550173
- Corriere T, Di Marca S, Cataudella E, et al. Neutrophil-to-Lymphocyte Ratio is a strong predictor of atherosclerotic carotid plaques in older adults. Nutr Metab Cardiovasc Dis. 2018;28:23-27.10.1016/j.numecd.2017.10.02229241668
- Tatar E, Mirili C, Isikyakar T, et al. The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3-5 chronic kidney disease. Acta Clin Belg. 2016;71:221-226.10.1080/17843286.2016.115979727309205
- Turkmen K, Erdur FM, Ozcicek F, et al. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int. 2013;17:391-396.10.1111/hdi.1204023522328